XXB750

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for XXB750, covering 2024-08-16 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure [Phase 2]